Nidan Laboratories And Healthcare Limited (NSE: NIDAN) is a Palghar, Maharashtra-based company in the Medical Diagnostic Centres industry. With a market capitalisation of ₹17 Cr, it ranks #4,749 by market cap among the 6,189 Indian listed companies on FinBizNet, and #13 of 18 in Medical Diagnostic Centres. At ₹12.30 (as of 26 Oct 2026), the share price is 50.6% below its 52-week high of ₹24.90 and 7.0% above its 52-week low of ₹11.50. The share price is down 35.3% over one year and down 1.6% over three months.
| Current Price | ₹12.30 |
|---|---|
| Market Cap | ₹17 Cr |
| NSE Symbol | NIDAN |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Diagnostic Centres |
| P/E Ratio | 11.4 |
| Return on Equity | 2.19% |
| Return on Assets | 2.22% |
| 52-Week Range | ₹11.50 – ₹24.90 |
| 1-Year Price Change | -35.3% |
| 3-Month Price Change | -1.6% |
| Beta (1Y) | 0.2 |
| Headquarters | Palghar, Maharashtra |
| Website | www.nidanhealthcare.co.in |
Nidan Laboratories and Healthcare Limited provides healthcare and diagnostic services in India. It offers diagnostic services, including pathology, radiology, cardiology, and neurology services. The company was founded in 1994 and is headquartered in Palghar, India.
1. Diagnostic Centre-This segment operates in the diagnostic centre business.
1. Diagnostic Centre-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Vijaya Diagnostic Centre Limited | ₹14,311 Cr | 82.8 | 19.70% | ₹231 Cr | +40.7% |
| Metropolis Healthcare Limited | ₹10,849 Cr | 56.9 | 13.37% | ₹450 Cr | +7.3% |
| Throcare Technologies Ltd | ₹7,357 Cr | 45.3 | 28.74% | ₹240 Cr | +8.9% |
| Dr. Agarwal'S Eye Hospital Ltd | ₹2,434 Cr | 34.3 | 25.22% | — | +20.0% |
| Krsnaa Diagnostics Ltd | ₹1,617 Cr | 16.1 | 10.89% | ₹236 Cr | -38.8% |
| SURAKSHA DIAGNOSTIC LIMITED | ₹1,559 Cr | 48.4 | 13.84% | ₹88 Cr | -0.3% |
| Gaudium IVF and Women Health Limited | ₹670 Cr | 23.5 | 16.08% | ₹19 Cr | — |
| Chandan Healthcare Limited | ₹535 Cr | 20.3 | — | ₹81 Cr | — |
| Nidan Laboratories And Healthcare Limited | ₹17 Cr | 11.4 | 2.19% | — | -35.3% |
Listed by market capitalisation. Ratios are shown for context only.
Nidan Laboratories And Healthcare Limited is trading at ₹12.30, with a market capitalisation of ₹17 Cr.
Nidan Laboratories And Healthcare Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Diagnostic Centres).
Nidan Laboratories And Healthcare Limited has a P/E of 11.4 and a return on equity of 2.19%.
Nidan Laboratories And Healthcare Limited is listed on the NSE under the symbol NIDAN.
Nidan Laboratories And Healthcare Limited's share price is down 35.3% over one year and down 1.6% over three months. Its 52-week range is ₹11.50 to ₹24.90.
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.